A Phase I Study to Evaluate Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Individuals
Clinical trial NCT05305300 · COMPLETED
Trial details
- NCT number
- NCT05305300
- Sponsor
- Yisheng Biopharma (Singapore) Pte. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2022-05-15
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.